BioStem Technologies (BSEM) to Release Earnings on Thursday

BioStem Technologies (OTCMKTS:BSEM) is expected to post its Q2 2025 quarterly earnings results after the market closes on Thursday, August 14th. Analysts expect BioStem Technologies to post earnings of $0.32 per share and revenue of $78.22 million for the quarter.

BioStem Technologies (OTCMKTS:BSEM) last issued its earnings results on Monday, May 12th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $1.25 by ($1.08). The company had revenue of $72.53 million for the quarter, compared to the consensus estimate of $101.20 million. On average, analysts expect BioStem Technologies to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

BioStem Technologies Stock Performance

Shares of BioStem Technologies stock opened at $10.05 on Tuesday. The company has a market capitalization of $168.34 million, a P/E ratio of 6.84 and a beta of -0.29. The company has a fifty day moving average of $12.26 and a 200 day moving average of $12.38. BioStem Technologies has a fifty-two week low of $6.95 and a fifty-two week high of $28.26.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.